Literature DB >> 21565851

Acute stimulation of glucagon secretion by linoleic acid results from GPR40 activation and [Ca2+]i increase in pancreatic islet {alpha}-cells.

Li Wang1, Yufeng Zhao, Baosong Gui, Rongguo Fu, Feng Ma, Jun Yu, Ping Qu, Lei Dong, Chen Chen.   

Abstract

The role of free fatty acids (FFAs) in glucagon secretion has not been well established, and the involvement of FFA receptor GPR40 and its downstream signaling pathways in regulating glucagon secretion are rarely demonstrated. In this study, it was found that linoleic acid (LA) acutely stimulated glucagon secretion from primary cultured rat pancreatic islets. LA at 20 and 40 μmol/l dose-dependently increased glucagon secretion both at 3 mmol/l glucose and at 15 mmol/l glucose, although 15 mmol/l glucose reduced basal glucagon levels. LA induced an increase in cytoplasmic free calcium concentrations ([Ca(2)(+)](i)) in identified rat α-cells, which is reflected by increased Fluo-3 intensity under confocal microscopy recording. The increase in [Ca(2)(+)](i) was partly inhibited by removal of extracellular Ca(2)(+) and eliminated overall by further exhaustion of intracellular Ca(2)(+) stores using thapsigargin treatment, suggesting that both Ca(2)(+) release and Ca(2)(+) influx contributed to the LA-stimulated increase in [Ca(2)(+)](i) in α-cells. Double immunocytochemical stainings showed that GPR40 was expressed in glucagon-positive α-cells. LA-stimulated increase in [Ca(2)(+)](i) was blocked by inhibition of GPR40 expression in α-cells after GPR40-specific antisense treatment. The inhibition of phospholipase C activity by U73122 also blocked the increase in [Ca(2)(+)](i) by LA. It is concluded that LA activates GPR40 and phospholipase C (and downstream signaling pathways) to increase Ca(2)(+) release and associated Ca(2)(+) influx through Ca(2)(+) channels, resulting in increase in [Ca(2)(+)](i) and glucagon secretion.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21565851     DOI: 10.1530/JOE-11-0132

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  14 in total

Review 1.  G protein-coupled receptors as targets for anti-diabetic therapeutics.

Authors:  Da Young Oh; Jerrold M Olefsky
Journal:  Nat Rev Drug Discov       Date:  2016-01-29       Impact factor: 84.694

Review 2.  Targeting lipid GPCRs to treat type 2 diabetes mellitus - progress and challenges.

Authors:  Julien Ghislain; Vincent Poitout
Journal:  Nat Rev Endocrinol       Date:  2021-01-25       Impact factor: 43.330

3.  Acute dietary fat intake initiates alterations in energy metabolism and insulin resistance.

Authors:  Elisa Álvarez Hernández; Sabine Kahl; Anett Seelig; Paul Begovatz; Martin Irmler; Yuliya Kupriyanova; Bettina Nowotny; Peter Nowotny; Christian Herder; Cristina Barosa; Filipa Carvalho; Jan Rozman; Susanne Neschen; John G Jones; Johannes Beckers; Martin Hrabě de Angelis; Michael Roden
Journal:  J Clin Invest       Date:  2017-01-23       Impact factor: 14.808

Review 4.  Free fatty acid receptor 1: a ray of hope in the therapy of type 2 diabetes mellitus.

Authors:  Arpita Arora; Tapan Behl; Aayush Sehgal; Sukhbir Singh; Neelam Sharma; Sridevi Chigurupati; Rajwinder Kaur; Saurabh Bhatia; Ahmed Al-Harrasi; Celia Vargas-De-La-Cruz; Simona Bungau
Journal:  Inflammopharmacology       Date:  2021-10-20       Impact factor: 4.473

5.  Alteration of the glucagon axis in GPR120 (FFAR4) knockout mice: a role for GPR120 in glucagon secretion.

Authors:  Arthur T Suckow; David Polidori; Wen Yan; Suhyoun Chon; Jing Ying Ma; James Leonard; Celia P Briscoe
Journal:  J Biol Chem       Date:  2014-04-17       Impact factor: 5.157

Review 6.  Drugs or diet?--Developing novel therapeutic strategies targeting the free fatty acid family of GPCRs.

Authors:  H J Dranse; M E M Kelly; B D Hudson
Journal:  Br J Pharmacol       Date:  2013-10       Impact factor: 8.739

7.  A novel GPR40 agonist, CNX-011-67, suppresses glucagon secretion in pancreatic islets under chronic glucolipotoxic conditions in vitro.

Authors:  Mahesh Kumar Verma; Sanghamitra Biswas; Bhawna Chandravanshi; Korrapati Neelima; Anup M Oommen; Madanahalli R Jagannath; Baggavalli P Somesh
Journal:  BMC Res Notes       Date:  2014-09-03

8.  Basal hypersecretion of glucagon and insulin from palmitate-exposed human islets depends on FFAR1 but not decreased somatostatin secretion.

Authors:  H Kristinsson; E Sargsyan; H Manell; D M Smith; S O Göpel; P Bergsten
Journal:  Sci Rep       Date:  2017-07-05       Impact factor: 4.379

Review 9.  Treatment of type 2 diabetes by free Fatty Acid receptor agonists.

Authors:  Kenneth R Watterson; Brian D Hudson; Trond Ulven; Graeme Milligan
Journal:  Front Endocrinol (Lausanne)       Date:  2014-08-28       Impact factor: 5.555

10.  20-HETE promotes glucose-stimulated insulin secretion in an autocrine manner through FFAR1.

Authors:  Sorin Tunaru; Remy Bonnavion; Isabell Brandenburger; Jens Preussner; Dominique Thomas; Klaus Scholich; Stefan Offermanns
Journal:  Nat Commun       Date:  2018-01-12       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.